menu
    • menu

    Company profile for Kintara Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kintara Therapeutics is dedicated to the development of novel cancer therapies for patients with unmet medical needs. Kintara Therapeutics has teamed up with outstanding academic and clinical research institutions from around the world to support the development of our novel cancer therapies.Our main focus is the patients and their families. We are dedicated to improving patient outcomes and their quality of life.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kintara TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9920 Pacific Heights Blvd, Suite 150 San Diego, CA, 92121
    Telephone
    Telephone
    858-350-4364
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kintara.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kintara-therapeutics/?viewAsMember=true
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kintara Corrects Announcement On Reverse Stock Split Merger
    Kintara Corrects Announcement On Reverse Stock Split Merger

    16 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kintara-therapeutics-announces-correction-to-prior-announcement-regarding-1-for-35-reverse-stock-split-in-connection-with-the-proposed-merger-with-tuhura-biosciences-to-close-on-october-18-2024-302278235.html

    PR NEWSWIRE
    16 Oct 2024
    Share Share
    Kintara Announces 1-For-35 Reverse Stock Split For Merger with TuHURA
    Kintara Announces 1-For-35 Reverse Stock Split For Merger with TuHURA

    16 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kintara-therapeutics-announces-1-for-35-reverse-stock-split-in-connection-with-the-proposed-merger-with-tuhura-biosciences-302278139.html

    PR NEWSWIRE
    16 Oct 2024
    Share Share
    Kintara Therapeutics Announces Correction On CVR Issuance
    Kintara Therapeutics Announces Correction On CVR Issuance

    15 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kintara-therapeutics-announces-correction-to-prior-announcement-regarding-cvr-issuance-in-connection-with-the-proposed-merger-with-tuhura-biosciences-expected-to-close-on-october-18-2024-302276973.html

    PR NEWSWIRE
    15 Oct 2024
    Share Share
    Kintara Therapeutics Announces Record Date For CVR Issuance
    Kintara Therapeutics Announces Record Date For CVR Issuance

    14 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kintara-therapeutics-announces-record-date-for-cvr-issuance-in-connection-with-the-proposed-merger-with-tuhura-biosciences-expected-to-close-on-october-18-2024-302274616.html

    PR NEWSWIRE
    14 Oct 2024
    Share Share
    Kintara Therapeutics Announces Fiscal 2024 Results And Update
    Kintara Therapeutics Announces Fiscal 2024 Results And Update

    08 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kintara-therapeutics-announces-fiscal-2024-financial-results-and-provides-corporate-update-302269448.html

    PR NEWSWIRE
    08 Oct 2024
    Share Share
    Kintara Adjourns Special Meeting of Stockholders To October 4
    Kintara Adjourns Special Meeting of Stockholders To October 4

    20 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kintara-therapeutics-announces-adjournment-of-special-meeting-of-stockholders-until-october-4-2024-302253764.html

    PR NEWSWIRE
    20 Sep 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search